| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $24,662 | 1 | 4 |
Sells | $56,325,494 | 24 | 96 |
| AGEE NANCY H | director | 1 | $24,662 | 0 | $0 | $24,662 |
| Lehr Donald P. | Chief Legal Officer | 0 | $0 | 1 | $127,011 | $-127,011 |
| Tennant Phil | Chief Commercial Officer | 0 | $0 | 2 | $725,731 | $-725,731 |
| Shah Rutul R | Chief Operating Officer | 0 | $0 | 6 | $1.26M | $-1.26M |
| Thomasian Harry Jr. | Chief Financial Officer | 0 | $0 | 4 | $1.9M | $-1.9M |
| KINDLER JEFFREY B | director | 0 | $0 | 2 | $2.23M | $-2.23M |
| Sabzevari Helen | President and CEO | 0 | $0 | 2 | $2.56M | $-2.56M |
| KIRK RANDAL J | 0 | $0 | 7 | $47.52M | $-47.52M |
Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies. Its extensive portfolio of proprietary platforms includes UltraVector, which leverages advanced DNA construction and computational modeling to engineer complex gene expression programs; mbIL15, a gene designed to enhance immune cell function; the …
Over the last 12 months, insiders at Precigen, Inc. have bought $24,662 and sold $56.33M worth of Precigen, Inc. stock.
On average, over the past 5 years, insiders at Precigen, Inc. have bought $9.37M and sold $16.59M worth of stock each year.
Highest buying activity among insiders over the last 12 months: AGEE NANCY H (director) — $24,662.
The last purchase of 3,411 shares for transaction amount of $24,662 was made by AGEE NANCY H (director) on 2026‑08‑21.
| 2026-08-26 | Sale | KINDLER JEFFREY B | director | 185,000 0.052% | $7.44 | $1.38M | -4.04% | |
| 2026-08-25 | Sale | Shah Rutul R | Chief Operating Officer | 15,342 0.0044% | $7.50 | $115,065 | -1.92% | |
| 2026-08-25 | Sale | Tennant Phil | Chief Commercial Officer | 79,166 0.0229% | $7.50 | $593,745 | -1.92% | |
| 2026-08-21 | Sale | Shah Rutul R | Chief Operating Officer | 34,658 0.0101% | $7.50 | $259,935 | -0.42% | |
| 2026-08-21 | AGEE NANCY H | director | 3,411 0.001% | $7.23 | $24,662 | -0.42% | ||
| 2026-08-06 | Sale | Shah Rutul R | Chief Operating Officer | 32,739 0.0091% | $6.86 | $224,590 | +3.04% | |
| 2026-08-03 | Sale | Shah Rutul R | Chief Operating Officer | 33,772 0.0106% | $6.50 | $219,518 | +6.05% | |
| 2026-07-31 | Sale | Thomasian Harry Jr. | Chief Financial Officer | 100,000 0.0271% | $6.06 | $606,000 | +11.72% | |
| 2026-07-01 | Sale | Thomasian Harry Jr. | Chief Financial Officer | 171,429 0.0554% | $5.53 | $948,002 | +30.48% | |
| 2026-06-29 | Sale | Sabzevari Helen | President and CEO | 346,836 0.1149% | $5.89 | $2.04M | +15.71% | |
| 2026-06-29 | Sale | Thomasian Harry Jr. | Chief Financial Officer | 28,571 0.0093% | $5.78 | $165,140 | +15.71% | |
| 2026-06-29 | Sale | Shah Rutul R | Chief Operating Officer | 42,924 0.0141% | $5.85 | $251,105 | +15.71% | |
| 2026-05-28 | Sale | Sabzevari Helen | President and CEO | 119,250 0.0384% | $4.36 | $519,930 | +45.01% | |
| 2026-05-28 | Sale | Lehr Donald P. | Chief Legal Officer | 29,131 0.0094% | $4.36 | $127,011 | +45.01% | |
| 2026-05-28 | Sale | Thomasian Harry Jr. | Chief Financial Officer | 41,884 0.0135% | $4.36 | $182,614 | +45.01% | |
| 2026-05-28 | Sale | Shah Rutul R | Chief Operating Officer | 42,703 0.0137% | $4.36 | $186,185 | +45.01% | |
| 2026-05-28 | Sale | Tennant Phil | Chief Commercial Officer | 30,272 0.0097% | $4.36 | $131,986 | +45.01% | |
| 2026-03-30 | Sale | KIRK RANDAL J | 1.11M 0.3748% | $3.30 | $3.66M | +69.85% | ||
| 2026-03-30 | Sale | KIRK RANDAL J | 4.77M 1.6131% | $3.30 | $15.75M | +69.85% | ||
| 2025-12-22 | Sale | KIRK RANDAL J | 1.88M 0.5985% | $4.18 | $7.88M | +8.22% |
| Sabzevari Helen | President and CEO | 3768872 1.0527% | $19.79M | 1 | 25 | <0.0001% |
| Lehr Donald P. | Chief Legal Officer | 755461 0.211% | $3.97M | 2 | 22 | +21.62% |
| Shah Rutul R | Chief Operating Officer | 468865 0.131% | $2.46M | 2 | 10 | <0.0001% |
| AGEE NANCY H | director | 309187 0.0864% | $1.62M | 4 | 0 | +3.85% |
| KIRK RANDAL J | 302213 0.0844% | $1.59M | 70 | 22 | +6.88% | |
| Thomasian Harry Jr. | Chief Financial Officer | 254535 0.0711% | $1.34M | 5 | 9 | <0.0001% |
| Tennant Phil | Chief Commercial Officer | 141992 0.0397% | $745,458.00 | 1 | 2 | +16.8% |
| KINDLER JEFFREY B | director | 17100 0.0048% | $89,775.00 | 2 | 6 | <0.0001% |
| Ares Trading S.A. | 10 percent owner | 20647152 5.7668% | $108.4M | 1 | 67 | +52.74% |
| Frank Steven | director | 882358 0.2464% | $4.63M | 1 | 0 | <0.0001% |
| Hassan Fred | director | 878942 0.2455% | $4.61M | 2 | 0 | <0.0001% |
| Perez Jeffrey Thomas | SVP, IP Affairs | 743097 0.2075% | $3.9M | 3 | 20 | <0.0001% |
| MITCHELL DEAN J | director | 356836 0.0997% | $1.87M | 2 | 0 | <0.0001% |
| Reed Thomas D. | Chief Science Officer | 148888 0.0416% | $781,662.00 | 2 | 9 | +21.52% |
| Frost Gregory Ian | SVP--Health Sector | 100000 0.0279% | $525,000.00 | 3 | 0 | <0.0001% |
| LIFFMAN JOEL D | SVP, Finance | 85541 0.0239% | $449,090.25 | 1 | 2 | <0.0001% |
| SHAPIRO ROBERT B | director | 82966 0.0232% | $435,571.50 | 2 | 0 | <0.0001% |
| Krishnan Krish S | Chief Operating Officer | 42000 0.0117% | $220,500.00 | 1 | 2 | +59.01% |
| Krishnan Suma | SVP--Product Development | 42000 0.0117% | $220,500.00 | 1 | 2 | +59.01% |
| Kasser Thomas R. | SVP--Food Sector | 15000 0.0042% | $78,750.00 | 2 | 0 | +19.61% |
| Nimrodi Nir | Chief Business Officer | 5708 0.0016% | $29,967.00 | 2 | 1 | <0.0001% |
| Last Andrew J. | Chief Operating Officer | 4000 0.0011% | $21,000.00 | 2 | 0 | +0.56% |
| Huang Kelly | SVP-Consumer Sector | 3200 0.0009% | $16,800.00 | 1 | 0 | +59.01% |
| Gupta Vinita D | director | 3000 0.0008% | $15,750.00 | 1 | 0 | <0.0001% |
Precigen, Inc. (PGEN) | $607,395,062 | 99 | 4.23% | $1.88B |
$47,419,530 | 58 | 17.20% | $1.96B | |
$1,376,668 | 53 | 18.46% | $2.1B | |
$61,893,001 | 38 | 19.63% | $1.89B | |
$678,065,999 | 37 | -13.32% | $1.97B |
| Increased Positions | 115 | +81.56% | 47M | +42.1% |
| Decreased Positions | 55 | -39.01% | 21M | -19.21% |
| New Positions | 38 | New | 6M | New |
| Sold Out Positions | 20 | Sold Out | 4M | Sold Out |
| Total Postitions | 201 | +42.55% | 137M | +22.89% |
| Patient Capital Management, Llc | $113,252.00 | 7.48% | 26.46M | +10M | +62.65% | 2025-09-30 |
| Tang Capital Management Llc | $53,072.00 | 3.5% | 12.4M | +12M | New | 2025-09-30 |
| Blackrock, Inc. | $52,002.00 | 3.43% | 12.15M | +1M | +9.01% | 2025-09-30 |
| Vanguard Group Inc | $38,273.00 | 2.53% | 8.94M | -127,744 | -1.41% | 2025-09-30 |
| State Street Corp | $19,216.00 | 1.27% | 4.49M | +1M | +48.22% | 2025-09-30 |
| Geode Capital Management, Llc | $16,473.00 | 1.09% | 3.85M | +99,556 | +2.65% | 2025-09-30 |
| Iridian Asset Management Llc/Ct | $15,695.00 | 1.04% | 3.67M | -611,716 | -14.3% | 2025-09-30 |
| Point72 Asset Management, L.P. | $11,732.00 | 0.77% | 2.74M | +3M | New | 2025-09-30 |
| Occam Crest Management Lp | $11,545.00 | 0.76% | 2.7M | +3M | New | 2025-09-30 |
| Citadel Advisors Llc | $11,538.00 | 0.76% | 2.7M | +2M | +756.35% | 2025-09-30 |